UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 5
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[   ] Check box if no longer subject to Section 16. Form 4 or Form 5 obligations
    may continue.

[ ] Form 3 Holdings Reported

[ ] Form 4 Transactions Reported

1. Name and Address of Reporting Person(s)

   Gary S. Kledzik
   336 Bollay Drive
   Santa Barbara, CA  93117

2. Issuer Name and Ticker or Trading Symbol

   Miravant Medical Technologies (MRVT)

3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)

4. Statement for Month/Year

   12/01

5. If Amendment, Date of Original (Month/Year)

6. Relationship of Reporting Person(s) to Issuer (Check all applicable)

   [X] Director                   [ ] 10% Owner
   [X] Officer (give title below) [ ] Other (specify below)
       Chief Executive Officer

7. Individual or Joint/Group Filing (Check Applicable Line)

   [X] Form filed by One Reporting Person
   [ ] Form filed by More than One Reporting Person



Table I   Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
------------------------------------------------------------------------------------------------------------------------------------
1)Title of Security                           2)Trans-    3.Trans- 4.Securities Acquired(A)      5)Amount of    6)  7)Nature of
                                              action      action   or Disposed of (D)            Securities         Indirect
                                              Date        Code                   A               Beneficially   D   Beneficial
                                              (Month/                            or              Owned at       or  Ownership
                                              Day/Year)   Code     Amount        D  Price        End of Year    I
------------------------------------------------------------------------------------------------------------------------------------
                                                                                           



Table II (PART 1) Derivative Securitites Acquired, Disposed of, or Beneficially
Owned (Columns 1 through 6)
------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative          2)Conversion    3)Trans-       4)Trans-  5)Number of Derivative            6)Date Exercisable and
Security                       or Exercise     action         action    Securities Acquired (A)           Expiration Date
                               Price of        Date           Code      or Disposed of (D)
                               Derivative
                               Security                       Code      A                D                Exercisable  Expiration
------------------------------------------------------------------------------------------------------------------------------------
                                                                                                  
Incentive Stock Option (right  $8.7500         01/12/01       A         11,428                            01/12/02 (1) 01/12/11
to buy)
Non-Qualified Stock Option     $8.7500         01/12/01       A         188,572                           01/12/02 (1) 01/12/11
(right to buy)


Table II (PART 2) Derivative Securitites Acquired, Disposed of, or Beneficially
Owned (Columns 1,3 and 7 through 11)
------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative          3)Trans-  7)Title and Amount                           8)Price     9)Number of   10) 11)Nature of
Security                       action    of Underlying                                of Deri-    Derivative        Indirect
                               Date      Securities                                   vative      Securities    D   Beneficial
                                                                        Amount or     Security    Beneficially  or  Ownership
                                                                        Number of                 Owned at      I
                  -                      Title                          Shares                    End of Year
------------------------------------------------------------------------------------------------------------------------------------
                                                                                               

Incentive Stock Option (right  01/12/01  Common Stock                   11,428        $8.7500     11,428        D   Direct
to buy)
Non-Qualified Stock Option     01/12/01  Common Stock                   188,572       $8.7500     188,572       D   Direct
(right to buy)


Explanation of Responses:

(1)  The  cumulative  option grant vests  ratably and annually  over a four year
     period  commencing on date  indicated  when the first 25% vests and becomes
     exercisable.



SIGNATURE OF REPORTING PERSON

/S/ Gary S. Kledzik
-------------------
    Gary S. Kledzik

DATE February 6, 2002